MCID: VGN019
MIFTS: 34

Vaginal Discharge

Categories: Reproductive diseases

Aliases & Classifications for Vaginal Discharge

MalaCards integrated aliases for Vaginal Discharge:

Name: Vaginal Discharge 12 44 15

Classifications:



External Ids:

Disease Ontology 12 DOID:3767
MeSH 44 D019522
NCIt 50 C50795
SNOMED-CT 68 70856007
UMLS 73 C0227791

Summaries for Vaginal Discharge

Disease Ontology : 12 A vaginal disease that is characterized by the presence of discharge.

MalaCards based summary : Vaginal Discharge is related to endometritis and bacterial vaginosis. An important gene associated with Vaginal Discharge is DSPP (Dentin Sialophosphoprotein). The drugs Metronidazole and Povidone-iodine have been mentioned in the context of this disorder. Affiliated tissues include cervix, testes and colon.

Wikipedia : 76 Vaginal discharge is a mixture of liquid, cells, and bacteria that lubricates and protects the vagina.... more...

Related Diseases for Vaginal Discharge

Diseases related to Vaginal Discharge via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 55)
# Related Disease Score Top Affiliating Genes
1 endometritis 30.3 HP PGF
2 bacterial vaginosis 11.7
3 vaginitis 11.6
4 pelvic inflammatory disease 11.6
5 leukorrhea 11.6
6 trichomoniasis 11.5
7 chlamydia 11.5
8 trichomonas vaginalis trichomoniasis 11.1
9 fallopian tube carcinoma 11.1
10 vulvovaginal candidiasis 11.1
11 uterine carcinosarcoma 11.1
12 fitz-hugh-curtis syndrome 11.1
13 retinitis pigmentosa, y-linked 10.1 GYPC HPSE2
14 candidiasis 10.0
15 vulvovaginitis 10.0
16 endometrial disease 10.0 DSPP HP PGF
17 fallopian tube disease 10.0 EXTL3 MAPK8IP1
18 radiation cystitis 10.0 MAPK8IP1 PGF
19 hereditary elliptocytosis 10.0 GYPC SPTB
20 vaginal disease 10.0 EXTL3 HP SPTB
21 uterine anomalies 9.9 HPSE2 MAPK8IP1
22 congenital hemolytic anemia 9.9 HP SPTB
23 breast cancer 9.8
24 hypercarotenemia and vitamin a deficiency, autosomal dominant 9.8
25 klippel-trenaunay-weber syndrome 9.8
26 pemphigus vulgaris, familial 9.8
27 renal hypodysplasia/aplasia 1 9.8
28 uterus bicornis bicollis with partial vaginal septum and unilateral hematocolpos with ipsilateral renal agenesis 9.8
29 adenomyosis 9.8
30 cervical cancer 9.8
31 lymphangioleiomyomatosis 9.8
32 human immunodeficiency virus type 1 9.8
33 pemphigus vulgaris 9.8
34 sacrococcygeal teratoma 9.8
35 ulcerative colitis 9.8
36 colitis 9.8
37 keratomalacia 9.8
38 leiomyoma 9.8
39 acute cystitis 9.8
40 schistosomiasis 9.8
41 lymphangioma 9.8
42 ectropion 9.8
43 cystitis 9.8
44 cervicitis 9.8
45 papilloma 9.8
46 endometriosis 9.8
47 teratoma 9.8
48 adenoma 9.8
49 appendicitis 9.8
50 vasculitis 9.8

Graphical network of the top 20 diseases related to Vaginal Discharge:



Diseases related to Vaginal Discharge

Symptoms & Phenotypes for Vaginal Discharge

Drugs & Therapeutics for Vaginal Discharge

Drugs for Vaginal Discharge (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 120)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Metronidazole Approved Phase 4,Phase 2,Phase 3,Not Applicable 443-48-1 4173
2
Povidone-iodine Approved Phase 4,Phase 3 25655-41-8
3
Povidone Approved Phase 4,Phase 3 9003-39-8
4
Iodine Approved, Investigational Phase 4,Phase 3 7553-56-2 807
5
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3 55-56-1 2713 9552079
6
Clindamycin Approved, Vet_approved Phase 4,Phase 3 18323-44-9 29029
7
Clotrimazole Approved, Vet_approved Phase 4,Phase 3 23593-75-1 2812
8 Anti-Infective Agents Phase 4,Phase 2,Phase 3,Not Applicable
9 Antiparasitic Agents Phase 4,Phase 2,Phase 3,Not Applicable
10 Antiprotozoal Agents Phase 4,Phase 2,Phase 3,Not Applicable
11 Disinfectants Phase 4,Phase 3
12 Micronutrients Phase 4,Phase 3,Not Applicable
13 Chlorhexidine gluconate Phase 4,Phase 3
14 Trace Elements Phase 4,Phase 3,Not Applicable
15 Anti-Infective Agents, Local Phase 4,Phase 3
16 Blood Substitutes Phase 4,Phase 3
17 cadexomer iodine Phase 4,Phase 3
18 Dermatologic Agents Phase 4,Phase 3
19 Pharmaceutical Solutions Phase 4,Phase 2,Phase 3
20 Plasma Substitutes Phase 4,Phase 3
21 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Not Applicable
22 Clindamycin palmitate Phase 4,Phase 3
23 Clindamycin phosphate Phase 4,Phase 3
24 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Not Applicable
25 Chlorquinaldol Phase 4
26
Secnidazole Approved Phase 3 3366-95-8
27
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
28
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2 22916-47-8 4189
29
Tinidazole Approved, Investigational Phase 3 19387-91-8 5479
30
Nystatin Approved, Vet_approved Phase 3 1400-61-9 11953884
31
Neomycin Approved, Vet_approved Phase 3 1404-04-2 8378
32
Aluminum sulfate Approved Phase 3 10043-01-3
33
Fluocinolone Acetonide Approved, Investigational, Vet_approved Phase 3 67-73-2 6215
34
Terconazole Approved Phase 3 67915-31-5 441383
35
Exemestane Approved, Investigational Phase 3 107868-30-4 60198
36
Tamoxifen Approved Phase 3,Phase 2 10540-29-1 2733526
37
Progesterone Approved, Vet_approved Phase 2, Phase 3,Not Applicable 57-83-0 5994
38
Imiquimod Approved, Investigational Phase 3 99011-02-6 57469
39
Betamethasone Approved, Vet_approved Phase 2, Phase 3 378-44-9 9782
40
Azithromycin Approved Phase 3 83905-01-5 55185 447043
41
Ketoconazole Approved, Investigational Phase 3 65277-42-1 3823 47576
42
Levonorgestrel Approved, Investigational Phase 3 17489-40-6, 797-63-7 13109
43 Estradiol valerate Approved, Investigational, Vet_approved Phase 3,Phase 2,Not Applicable 979-32-8
44
Polyestradiol phosphate Approved Phase 3,Phase 2,Not Applicable 28014-46-2
45
Ethinyl Estradiol Approved Phase 3,Not Applicable 57-63-6 5991
46
Desogestrel Approved Phase 3,Not Applicable 54024-22-5 40973
47
Estradiol Approved, Investigational, Vet_approved Phase 3,Phase 2,Not Applicable 50-28-2 5757
48
Etonogestrel Approved, Investigational Phase 3 54048-10-1 6917715 40976
49
Ethanol Approved Phase 3 64-17-5 702
50 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Not Applicable

Interventional clinical trials:

(show top 50) (show all 90)
# Name Status NCT ID Phase Drugs
1 Tolerance of Chlorhexidine Gluconate Vaginal Cleansing Solution Completed NCT03305159 Phase 4 Povidone-Iodine;4% Chlorhexidine Gluconate
2 Examining the Impact of Tampon Use on the Vaginal Microbiota Completed NCT03346759 Phase 4
3 Safety and Tolerability of Metronidazole Gel 1.3% Completed NCT02392026 Phase 4 Metronidazole Gel
4 Comparison of Two Topical Formulations Containing Clindamycin and Clotrimazole in Patients With Vaginal Infections Completed NCT01697826 Phase 4 ClinSupV3 -soft gelatin capsule;ClinSupV3ER- Extended release tablet
5 Treatment Comparison of Antibiotics Versus Vaginal Lactic Acid in Non-pregnant Women With Acute Symptomatic Bacterial Vaginosis Recruiting NCT02042287 Phase 4 Metronidazole
6 The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP) Active, not recruiting NCT02629510 Phase 4 Tachosil
7 Colposeptine for the Treatment of Bacterial Vaginosis Terminated NCT01153958 Phase 4 Colposeptine;Metronidazole
8 A Pilot Open-label Randomized Study of Lactofiltrum in Women With Bacterial Vaginosis Unknown status NCT01089348 Phase 2, Phase 3 Lactofiltrum + Metronidazole;Metronidazole
9 Safety and Clinical and Microbiological Efficacy of the Combination of Fluconazole and Secnidazole for the Treatment of Symptomatic Vaginal Discharge Completed NCT02111629 Phase 3 Fluconazole and Secnidazole
10 Study of the Management of Vaginal Discharge in West African Using Single Dose Treatments Completed NCT00313131 Phase 3 tinidazole+fluconazole vs metronidazole+clotrimazole
11 Assessment of the Efficacy of POLYGYNAX® in the Empirical Treatment of Infectious Vaginitis Completed NCT02515656 Phase 3 POLYGYNAX®;GYNODAKTARIN®;Placebo
12 A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women Completed NCT02210689 Phase 3 clindamycin phosphate vaginal cream 2%
13 The Value of Bacterial Loads by Real Time PCR in Predicting Recurrence of Abnormal Vaginal Flora After Oral Metronidazole Therapy Completed NCT01287728 Phase 3 Treatment BY METROMIDAZOLE
14 Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients Completed NCT00607295 Phase 3 clino-san vaginal lubricant
15 Diabetes Mellitus and Vulvovaginal Candidiasis Completed NCT00353561 Phase 3 Boric;Fluconazole
16 HerpeVac Trial for Young Women Completed NCT00057330 Phase 3
17 A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis Completed NCT02418845 Phase 3 SYM-1219;Placebo
18 A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis Completed NCT01867164 Phase 3 Gynoclin V;Vagitrol V
19 Pessary in Singleton Gestations With Short Cervix Without Prior Preterm Birth Completed NCT02716909 Phase 3
20 Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer Completed NCT00038467 Phase 3 Tamoxifen;Exemestane
21 The Study Of Fluconazole For Vulvovaginal Candidiasis Completed NCT01806623 Phase 3 Fluconazole
22 Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) Completed NCT02237950 Phase 3 Metronidazole oral tablets 500mg;1% SPL7013 Gel;Placebo gel
23 Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV) Completed NCT02236156 Phase 3 Metronidazole oral tablets 500mg;1% SPL7013 Gel;Placebo gel
24 Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol Recruiting NCT02669459 Phase 3 Imiquimod
25 Does a Rescue Course of Betamethasone in Pregnant Women With PPROM Decrease Neonatal Morbidity? Recruiting NCT02939742 Phase 2, Phase 3 Betamethasone;Placebo
26 Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death Recruiting NCT03199547 Phase 3 Azithromycin;Placebo Oral Tablet
27 Ketoconazole Gel Versus Terconazole Cream for Vaginal Candidiasis Not yet recruiting NCT03473418 Phase 3 Ketoconazole;Terconazole
28 Efficacy, Safety LactiSal 1% Gel, LactSal 50 mg, Clotrimazole 100 mg Tablet in Treatment Vulvovaginal Candidiasis Not yet recruiting NCT02907307 Phase 3 Clotrimazole vaginal tablet 100mg
29 Cervical Pessary vs Vaginal Progesterone in Preventing Preterm Birth Among Women Presenting With Short Cervix: An Open-label Randomized Controlled Trial Not yet recruiting NCT02470676 Phase 2, Phase 3 Progesterone
30 Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062) Terminated NCT02616146 Phase 3 ENG-E2 125 μg/300 μg vaginal ring;LNG-EE 150 μg/30 μg COC
31 A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections Terminated NCT00528008 Phase 3
32 Efficacy and Safety of the Association of Clotrimazole and Metronidazole in the Treatment of Vaginal Discharge From Different Etiologies. Withdrawn NCT02713139 Phase 3 Clotrimazole + Metronidazole;Metronidazole;Clotrimazole
33 Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection Completed NCT00305227 Phase 2 Lactin-V;Placebo
34 Metronidazole for Pulmonary Tuberculosis (South Korea) Completed NCT00425113 Phase 2 Metronidazole
35 A Phase 2 Study of SYM-1219 to Treat Bacterial Vaginosis Completed NCT02147899 Phase 2 SYM-1219;Placebo
36 Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis Completed NCT02709005 Phase 2 5% Monolaurin Vaginal Gel
37 Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis Completed NCT01055106 Phase 2 GW05;GW05;GW05;Metronidazole
38 Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery Completed NCT02225353 Phase 2 Progesterone Cervical Pessary 6.3 g;Progesterone 200 mg vaginal capsules;Progesterone Cervical Pessary 7.7 g
39 Tactile Electrosurgical Ablation in Cases of Dysfunctional Uterine Bleeding Completed NCT02248194 Phase 2
40 Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea Completed NCT02257918 Phase 2 AZD0914;Ceftriaxone
41 CAMB/MAT2203 in Patients With Mucocutaneous Candidiasis Recruiting NCT02629419 Phase 2 Amphotericin B
42 Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through the Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast Recruiting NCT02993159 Phase 2 Afimoxifene;Tamoxifen Citrate
43 Vaginal Creams to Reduce Vaginal Erosion in Pessary Users Withdrawn NCT02316249 Phase 2 Estradiol
44 The Treatment Effect of Chinese Herbal Compound Ointment on Atrophic Vaginitis Unknown status NCT02733731 Phase 1 Chinese Herbal Compound Ointment;Estriol
45 Safety and Efficacy of Vaginal Microbiota Transplant (VMT) in Women With Bacterial Vaginosis (BV) Not yet recruiting NCT03769688 Phase 1 Cervicovaginal secretions;Metronidazole gel
46 The Presence of Microbes in the Sperm and Their Impact on Sperm Capacitation and IVF Treatment Unknown status NCT02585297
47 Diagnosing Bacterial Vaginosis/Vaginitis (BV) Using the Gynecologene Test Method Unknown status NCT02558179
48 Efficiency of Amnion Graft to Prevent Intrauterine Adhesions After Hysteroscopic Surgery Unknown status NCT02132104 Not Applicable Femoston
49 Conservative Management of Symptomatic Pelvic Organ Prolapse Using Vaginal Pessaries: Generation of a Standardized Management Protocol Unknown status NCT02113969 Not Applicable
50 Is Routine Cervical Dilatation Necessary During Elective Caesarean Section? A Randomised Controlled Trial Unknown status NCT01954719 Not Applicable

Search NIH Clinical Center for Vaginal Discharge

Cochrane evidence based reviews: vaginal discharge

Genetic Tests for Vaginal Discharge

Anatomical Context for Vaginal Discharge

MalaCards organs/tissues related to Vaginal Discharge:

41
Cervix, Testes, Colon, Brain, Uterus, Kidney

Publications for Vaginal Discharge

Articles related to Vaginal Discharge:

(show top 50) (show all 348)
# Title Authors Year
1
Vaginal Discharge in a Pre-pubertal Girl Posing a Diagnostic Challenge. ( 29872604 )
2018
2
Response of lactating dairy cows with or without purulent vaginal discharge to gonadotropin-releasing hormone and prostaglandin F2I+. ( 29385599 )
2018
3
The Etiology of Vaginal Discharge Syndrome in Zimbabwe: Results from the Zimbabwe STI Etiology Study. ( 29465674 )
2018
4
2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. ( 30049258 )
2018
5
Relationship of vaginal discharge characteristics evaluated by Metricheck device to metabolic status in postpartum dairy cows. ( 30051632 )
2018
6
Chronic Vaginal Discharge After Uterine Fibroid Embolization. ( 30146213 )
2018
7
Randomized clinical trial to evaluate the efficacy of prostaglandin F2α to treat purulent vaginal discharge in lactating dairy cows. ( 30292549 )
2018
8
The demographic and clinical profiles of women presenting with vaginal discharge syndrome at primary care facilities in South Africa: Associations with age and implications for management. ( 30421718 )
2018
9
Risk factors associated with reproductive performance in Japanese dairy cows: vaginal discharge with flecks of pus or calving abnormality extend time to pregnancy. ( 30473578 )
2018
10
Effectiveness of intrauterine treatment with cephapirin in dairy cows with purulent vaginal discharge. ( 28043367 )
2017
11
Effects of intrauterine infusion of Escherichia coli lipopolysaccharide on uterine health, resolution of purulent vaginal discharge, and reproductive performance of lactating dairy cows. ( 28434752 )
2017
12
Purulent vaginal discharge in grazing dairy cows: Risk factors, reproductive performance, and prostaglandin F2I+ treatment. ( 28318582 )
2017
13
Sacrococcygeal teratoma presenting with vaginal discharge and polyp in an infant. ( 29269272 )
2017
14
Trichomonas vaginalis is very rare among women with vaginal discharge in Podlaskie province, Poland. ( 28612378 )
2017
15
Syndromic management of sexually transmissible infections in resource-poor settings: a systematic review with meta-analysis of the abnormal vaginal discharge flowchart for Neisseria gonorrhoea and Chlamydia trachomatis. ( 28838352 )
2017
16
Consider the Risk of Vesicouterine Fistula in the Event of Intermittent Fluid Vaginal Discharge after a Cesarean Section. ( 29090213 )
2017
17
Vaginal discharge concentrations of I^-human chorionic gonadotropin, creatinine, and urea for the diagnosis of premature rupture of membranes. ( 29197087 )
2017
18
An Insight to How Estate Women in Sri Lanka Manage Abnormal Vaginal Discharge. ( 28451566 )
2017
19
Effects of intrauterine infusion of Escherichia coli lipopolysaccharide on uterine mRNA gene expression and peripheral polymorphonuclear leukocytes in Jersey cows diagnosed with purulent vaginal discharge. ( 28434729 )
2017
20
Application of a bacteriological on-farm test to reduce antimicrobial usage in dairy cows with purulent vaginal discharge. ( 28237589 )
2017
21
Definitive Management of Persistent Vaginal Discharge Caused by Leiomyoma-endometrial Fistulas after Uterine Artery Embolization. ( 29223699 )
2017
22
Effect of diagnosis and treatment of clinical endometritis based on vaginal discharge score grading system in postpartum Holstein cows. ( 28740032 )
2017
23
Genetic and functional analysis of the bovine uterine microbiota. Part II: Purulent vaginal discharge versus healthy cows. ( 28259411 )
2017
24
Cervical cytopathological changes among women with vaginal discharge attending teaching hospital. ( 28469316 )
2017
25
Efficacy of Tamarindus indicus, Melia azadirach and Santalum album in syndromic management of abnormal vaginal discharge: A single-blind randomised controlled trial. ( 29257757 )
2017
26
Effect of Vaginal Hygiene Module to Attitudes and Behavior of Pathological Vaginal Discharge Prevention Among Female Adolescents in Slemanregency, Yogyakarta, Indonesia. ( 29282418 )
2017
27
Epidemiology and clinico-investigative study of organisms causing vaginal discharge. ( 28442807 )
2017
28
Primary chylous vaginal discharge demonstrated with noncontrast magnetic resonance lymphography. ( 28475249 )
2017
29
Effects of rumen-protected methionine and choline supplementation on vaginal discharge and uterine cytology of Holstein cows. ( 30255041 )
2017
30
High Risk Human Papilloma Virus Genotypes in Kurdistan Region in Patients with Vaginal Discharge. ( 27509950 )
2016
31
Low-Grade Appendiceal Mucinous Neoplasm Involving the Endometrium and Presenting with Mucinous Vaginal Discharge. ( 27843660 )
2016
32
Efficacy of syndromic management measured as symptomatic improvement in females with vaginal discharge syndrome. ( 27190409 )
2016
33
Variables associated with vaginal discharge after ultrasound-guided percutaneous microwave ablation for adenomyosis. ( 27087631 )
2016
34
Primary care management of women with persistent vaginal discharge. ( 27861272 )
2016
35
The Performance of the Vaginal Discharge Syndromic Management in Treating Vaginal and Cervical Infection: A Systematic Review and Meta-Analysis. ( 27706174 )
2016
36
Prepubertal vaginal discharge: Vaginoscopy to rule out foreign body. ( 27976557 )
2016
37
Study to Evaluate Targeted Management and Syndromic Management in Women Presenting with Abnormal Vaginal Discharge. ( 27651658 )
2016
38
Do female patients with nonpathological vaginal discharge need the same evaluation as for Dhat syndrome in males? ( 26985107 )
2016
39
Utility of Laboratory Diagnosis for Confirmation of the Syndromic Case Management in Married Indian Women with Vaginal Discharge. ( 27833516 )
2016
40
Co-infection with Bovine Herpesvirus 4 and Histophilus somni Significantly Extends the Service Period in Dairy Cattle with Purulent Vaginal Discharge. ( 26690881 )
2016
41
Sore throat A^ vaginal discharge A^ labial ulcer A^ Dx? ( 27474821 )
2016
42
Chronic vaginal discharge due to vesicovaginal fistula. ( 25876713 )
2015
43
A 78-Year-Old Woman with Fecaloid Vaginal Discharge. ( 26495410 )
2015
44
Randomized clinical trial of intrauterine cephapirin infusion in dairy cows for the treatment of purulent vaginal discharge and cytological endometritis. ( 26210270 )
2015
45
Alpha-fetoprotein as a tool to distinguish amniotic fluid from urine, vaginal discharge, and semen. ( 25569004 )
2015
46
Technical note: Intraobserver, interobserver, and test-retest reliabilities of an assessment of vaginal discharge from cows with and without acute puerperal metritis. ( 26026759 )
2015
47
Utility of microbiological profile of symptomatic vaginal discharge in rural women of reproductive age group. ( 25954668 )
2015
48
Menstrual hygiene practices and its association with reproductive tract infections and abnormal vaginal discharge among women in India. ( 26614609 )
2015
49
Effect of intrauterine dextrose on reproductive performance of lactating dairy cows diagnosed with purulent vaginal discharge under certified organic management. ( 25828665 )
2015
50
Chylocolporrhea or chylous vaginal discharge: diagnostic conundrum with therapeutic challenge. ( 26386963 )
2015

Variations for Vaginal Discharge

Expression for Vaginal Discharge

Search GEO for disease gene expression data for Vaginal Discharge.

Pathways for Vaginal Discharge

GO Terms for Vaginal Discharge

Biological processes related to Vaginal Discharge according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cellular response to hormone stimulus GO:0032870 8.62 DSPP PGF

Sources for Vaginal Discharge

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....